Clarify the Role of Inbrija for Parkinson's Disease

Inbrija (in-BREE-jah) will be the first INHALED levodopa for adults with Parkinson's disease.

Think of Inbrija as a fast-acting starts to work in about 10 minutes and lasts about an hour. It joins the only other "on demand" option...Apokyn (apomorphine), a subcutaneous injection.

Inbrija is used as needed to treat "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms (rigidity, tremor, etc) return, especially as Parkinson's progresses.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote